openPR Logo
Press release

Preclinical In-vivo Imaging Market Attracts Academic & CRO Demand in Booming Research with 6.40% CAGR (2024-2031) | Top Companies - Bruker Corporation, Siemens A.G, TriFoil Imaging, PerkinElmer

07-21-2025 11:06 AM CET | Health & Medicine

Press release from: DataM intelligence 4 Market Research LLP

Preclinical In-vivo Imaging Market

Preclinical In-vivo Imaging Market

"Preclinical In-vivo Imaging Market size was valued at USD 936.1 million in 2022 and is estimated to reach at a compound annual growth rate (CAGR) of 6.40% over the forecast period 2024-2031." As per DataM intelligence research report

As per our analysis The Preclinical In-Vivo Imaging market is expanding as researchers seek non-invasive techniques to visualize biological processes in live animal models. This technology enables early-stage drug development, disease tracking, and biomarker analysis with greater precision. Modalities like MRI, PET, and optical imaging are enhancing research accuracy and reducing animal use. Increased R&D investments and demand for faster, cost-effective preclinical trials are driving market growth. Pharmaceutical and biotech companies are rapidly adopting these tools for real-time therapeutic validation. The market continues to thrive as it bridges laboratory research with clinical translation more efficiently than ever before.

Download your exclusive sample report today: (corporate email gets priority access): https://www.datamintelligence.com/download-sample/preclinical-in-vivo-imaging-market?sp

Preclinical In-vivo Imaging Market Dynamics:

The preclinical in-vivo imaging market is driven by the rising need for non-invasive techniques to study disease progression, drug efficacy, and biological processes in animal models. Increased pharmaceutical and biotechnology R&D activities support the demand for imaging modalities like MRI, PET, CT, and optical imaging. Researchers rely on these systems for real-time, longitudinal monitoring of molecular and cellular events. The push toward precision medicine and personalized therapies also drives demand for advanced imaging in early-stage drug development. Academic and contract research organizations increasingly adopt these technologies for preclinical validation. Funding support from public and private sectors boosts innovation in imaging platforms.

Market growth is further fueled by technological advancements such as multimodal imaging systems, AI-powered image analysis, and high-resolution detectors. The growing focus on translational research and biomarker discovery expands the application of in-vivo imaging across oncology, neurology, and cardiology. Miniaturization of devices and user-friendly software interfaces enhance operational efficiency. Emerging economies are investing in life sciences infrastructure, increasing access to preclinical imaging tools. Strategic collaborations between imaging system manufacturers and research institutions accelerate innovation and adoption. As the demand for efficient, non-destructive preclinical research rises, the market is poised for sustained growth.

Preclinical In-vivo Imaging Market: Recent Industry Developments

✅Cancer Research: Recent advancements in imaging technologies are significantly contributing to cancer research by enabling real-time monitoring of tumor growth and response to therapies, thereby improving the understanding of cancer biology and treatment efficacy .

✅Drug Development: Enhanced imaging techniques are facilitating the evaluation of drug efficacy and safety profiles in preclinical stages, leading to more informed decision-making and potentially reducing the time required for clinical trials .

Strategic Players Driving the Preclinical In-vivo Imaging Market Forward:

Bruker Corporation, Siemens A.G, TriFoil Imaging, PerkinElmer, VisualSonics Inc. (Fujifilm), MILabs B.V., Mediso Ltd, Agilent Technologies

Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/preclinical-in-vivo-imaging-market?sp

Research Methodology:
The global Preclinical In-vivo Imaging Market research report employs a comprehensive dual-source approach, integrating both primary and secondary data collection methods to ensure robust market analysis. Our research framework systematically evaluates multiple industry-influencing variables, including regulatory frameworks and government policies, prevailing market conditions, competitive intensity levels, historical performance data, current market positioning, technological innovations and disruptions, emerging industry developments, cross-sector business impacts, market volatility patterns, growth prospects, potential market barriers, and strategic challenges facing industry participants.

Segment Covered in the Preclinical In-vivo Imaging Market:

♦By Modality: Optical Imaging Systems, Preclinical Nuclear Imaging Systems, Micro-MRI Systems, Micro-Ultrasound Systems, Micro-CT Systems, Preclinical Photoacoustic Imaging Systems, Preclinical Magnetic Particle Imaging (MPI) Systems

♦By Reagent: Preclinical Optical Imaging Reagents, Preclinical Nuclear Imaging Reagents, Preclinical MRI Contrast Agents, Preclinical Ultrasound Contrast Agents, Preclinical CT contrast agents

♦By Application: Research and development, Drug discovery

♦By Distribution Channel: Pharmaceutical companies, Biotechnology companies, Research institutes, Others

Regional Analysis for Preclinical In-vivo Imaging Market:

The Preclinical In-vivo Imaging market is growing due to increased drug development and demand for early-stage disease research. North America, especially the U.S., leads with strong R&D infrastructure and presence of key pharmaceutical players. Europe, including Germany, the U.K., and France, shows steady growth driven by academic collaborations and technological advancements. Asia-Pacific, particularly China, Japan, and India, is expanding rapidly with growing investments in biomedical research. South America, led by Brazil, is gradually developing capabilities in preclinical imaging. The Middle East & Africa show emerging potential, supported by improving research infrastructure and government-backed science initiatives.

Buy Now & Unlock 360° Market Intelligence: https://www.datamintelligence.com/buy-now-page?report=preclinical-in-vivo-imaging-market?sp

Unlock 360° Market Intelligence with DataM Subscription Services:
https://www.datamintelligence.com/reports-subscription?sp

✅ Competitive Landscape
✅ Technology Roadmap Analysis
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Consumer Behavior & Demand Analysis
✅ Import-Export Data Monitoring
✅ Live Market & Pricing Trends

Have a look at our Subscription Dashboard:
https://www.youtube.com/watch?v=x5oEiqEqTWg

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Preclinical In-vivo Imaging Market Attracts Academic & CRO Demand in Booming Research with 6.40% CAGR (2024-2031) | Top Companies - Bruker Corporation, Siemens A.G, TriFoil Imaging, PerkinElmer here

News-ID: 4111676 • Views:

More Releases from DataM intelligence 4 Market Research LLP

United States Hyperammonemia Market 2025 | Growth Drivers, Trends & Market Forecast, Competitive Landscape & Investment Opportunities
United States Hyperammonemia Market 2025 | Growth Drivers, Trends & Market Forec …
Market Size and Growth Global Hyperammonemia Market is expected to reach at a Significant CAGR during the forecast period 2024-2031. Key Development: United States: Recent Industry Developments ✅ July 2025: Amogy secured an additional $23 million in venture financing, bringing its total funding to $80 million. This investment aims to accelerate the company's growth and advance its ammonia-to-power solutions. ✅ July 2025: Navigator Gas announced a joint venture with Amon Maritime to construct two ammonia-fueled
United States Internet of Things (IoT) in Agriculture Market 2025 | Growth Drivers, Key Players & Investment Opportunities
United States Internet of Things (IoT) in Agriculture Market 2025 | Growth Drive …
Market Size and Growth Global Internet of Things (IoT) in Agriculture Market reached US$ 31.10 billion in 2023 and is expected to reach US$ 83.26 billion by 2031, growing with a CAGR of 13.1% during the forecast period 2024-2031. Recent Mergers and Acquisitions: United States: ✅ In Sep 2025, Sensei Farms (U.S.), backed by Larry Ellison, acquired ~25 acres in Lockhart, Texas - the former facility of robotics-farming company Iron Ox. While
United States Medical Device Coatings Market 2025 | Growth Drivers, Key Players & Investment Opportunities
United States Medical Device Coatings Market 2025 | Growth Drivers, Key Players …
Market Size and Growth Medical device coatings market is growing at a High CAGR during the forecast period 2024-2031. Recent Mergers and Acquisitions: United States: Recent Medical Device Coatings Developments ✅ In April 2025, the FDA granted 510(k) clearance to Becton Dickinson's CentroVena One central venous catheter, which features an advanced hydrophilic coating to improve device performance. ✅ In March 2025, the U.S. FTC filed suit to block GTCR's planned $627M acquisition of Surmodics
United States Nephrotic Syndrome Drugs Market 2025 | Growth Drivers, Trends & Market Forecast, Competitive Landscape & Investment Opportunities
United States Nephrotic Syndrome Drugs Market 2025 | Growth Drivers, Trends & Ma …
Market Size and Growth The global nephrotic syndrome drugs market reached US$ 423.7 million in 2023 and is expected to reach US$ 645.3 million by 2030, growing with a CAGR of 5.4% during the forecast period 2024-2031. Recent Mergers and Acquisitions: United States: ✅ In June 2025, Biogen initiated a Phase 3 study of felzartamab for the treatment of primary membranous nephropathy, a common cause of nephrotic syndrome. This trial aims to

All 5 Releases


More Releases for Preclinical

Driving Preclinical CRO Market Growth in 2025: The Role of Surging Demand For Pr …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. Preclinical CRO Market Size Growth Forecast: What to Expect by 2025? In recent times, there has been a significant increase in the size of the preclinical CRO market. The market will develop from being worth $5.7 billion in 2024 to achieving a value of $6.26 billion the following year,
DLL3 Inhibitors in Preclinical and Clinical Studies
Delta-Like Ligand 3 (DLL3) inhibitors have shown significant promise in preclinical and clinical studies, particularly for the treatment of aggressive cancers such as small cell lung cancer (SCLC) and neuroendocrine tumors. The selective expression of DLL3 in these malignancies makes it an attractive target for therapeutic intervention. This article explores the development and progress of DLL3 inhibitors in preclinical and clinical studies, highlighting their potential in modern oncology. Download Report: https://www.kuickresearch.com/report-dll3-targeted-therapies-dll3-cancer-therapies-dll3-protien-dll3-cancer-drugs-delta-like-ligand-3-dll3-gene-dll3-expression-dll3-amgen-dll3-inhibitor DLL3
Preclinical CRO Market Size Forecast Between 2023-2032
The global market for Preclinical Contract Research Organizations (CROs) has witnessed substantial growth in recent years, driven by increasing outsourcing of preclinical research activities by pharmaceutical and biotechnology companies. In 2022, the market size reached USD 5.2 Billion and is projected to grow to USD 10.7 Billion by 2032, with a compound annual growth rate (CAGR) of 7.6% from 2023 to 2032. This article delves into the current trends, drivers,
Preclinical Imaging Market Opportunity | Size | Research Report
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲-  Preclinical Imaging Market was valued at USD 748.18 Million in 2023 and is projected to reach USD 1,109.10 Million by 2030, growing at a CAGR of 5.0% from 2024 to 2030. The preclinical imaging market is being significantly driven by advancements in imaging modalities, such as MRI, PET, SPECT, CT, and optical imaging. These technologies provide researchers with non-invasive ways to visualize and study biological processes at the
Preclinical Imaging Market - Transforming Research with Precision Imaging: Precl …
Newark, New Castle, USA: The "Preclinical Imaging Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors Preclinical Imaging Market: https://www.growthplusreports.com/report/preclinical-imaging-market/7673 This latest report researches the industry structure, sales, revenue,
Preclinical Imaging Market - Unlocking Clarity, Preserving Scientific Excellence …
Newark, New Castle, USA - new report, titled Preclinical Imaging Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Preclinical Imaging market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Preclinical Imaging market. The report offers an overview of the market, which